PEP vs ABT vs MNST Stock Comparison

Pepsico, Abbott Laboratories and Monster Beverage Prices as of Oct 23, 2026 Peers: Industry group
PEP Pepsico Inc
$135.77 +4.3% 1M -10.4% 1Y
Market cap
$184.65B
P/E
16.9x
Revenue (TTM)
$98.24B
Div. yield
–
Non-Alcoholic Beverages Consumer Staples
8 wins
ABT Abbott Laboratories
$103.69 +0.2% 1M -17.9% 1Y
Market cap
$182.26B
P/E
33.6x
Revenue (TTM)
$46.59B
Div. yield
0.02%
Medical Devices Healthcare
MNST Monster Beverage Corp
$46.19 +5.2% 1M -33.9% 1Y
Market cap
$90.91B
P/E
42.7x
Revenue (TTM)
$9.22B
Div. yield
–
Non-Alcoholic Beverages Consumer Staples
3 wins

Head to Head

11 decided of 12

Pepsico leads on 8 of the 12 questions below (Pepsico 8, Monster Beverage 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionPEPABTMNSTLeader
Larger companyMarket capitalisation $184.65B $182.26B $90.91B PEP
Cheaper on earningsLower P/E, profitable companies only 16.9x 33.6x 42.7x PEP
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.8x 18.2x 38.5x PEP
Faster revenue growthRevenue growth, trailing twelve months +6.4% +8.1% +20.4% MNST
More profitableNet margin, trailing twelve months 11.1% 11.6% 23.1% MNST
Better return on capitalReturn on invested capital 16.1% 6.2% — PEP
Less leveragedLower net debt / EBITDA 2.2x 2.5x — PEP
Higher dividend yieldTrailing dividend yield 0.00% 0.02% 0.00% –
Better 1-year returnPrice return, last 12 months -10.4% -17.9% -33.9% PEP
Better 5-year returnAnnualised price return, 5 years -3.2%/yr -3.9%/yr +1.7%/yr MNST
Less volatileAnnualised volatility, 1 year 21.4% 27.4% 73.5% PEP
Higher overall scoreMean of the five percentile scores vs peers 64/100 57/100 61/100 PEP

Percentile Scorecard

PEPABTMNST

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisPEPABTMNST
Valuation 62 #15 of 38 68 #74 of 228 16 #32 of 38
Growth 59 #14 of 33 27 #162 of 222 69 #11 of 33
Profitability 87 #5 of 32 85 #33 of 210 94 #3 of 32
Financial Health 35 #25 of 38 38 #151 of 241 97 #2 of 38
Shareholder Returns 78 #6 of 24 66 #48 of 138 30 #17 of 24
Overall 64 57 61
  • PEP ranked among 41 companies in Beverages
  • ABT ranked among 248 companies in Medical Devices and Diagnostics
  • MNST ranked among 41 companies in Beverages

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodPEPABTMNSTSPY
1 month +4.3%+0.2%+5.2% -1.0%
3 months -0.6%+0.6%-50.6% +2.9%
6 months -12.7%+13.8%-41.0% +6.4%
Year to date -5.4%-17.2%-39.8% +11.4%
1 year -10.4%-17.9%-33.9% +13.1%
3 years -16.3%+9.4%-7.7% +79.4%
3 years, per year -5.8%+3.0%-2.6% +21.5%
5 years -15.1%-18.2%+9.0% +67.7%
5 years, per year -3.2%-3.9%+1.7% +10.9%
10 years +28.5%+156.0%+88.2% +255.2%
10 years, per year +2.5%+9.9%+6.5% +13.5%

Risk

MeasurePEPABTMNSTSPY
Volatility, 1Y 21.4%27.4%73.5% 12.7%
Downside volatility, 1Y 20.4%27.5%105.6% 12.7%
Beta vs S&P 500, 1Y -0.180.000.32 1.00
Return / volatility, 1Y -0.49-0.66-0.46 1.03
Max drawdown, 5Y -36.9%-41.6%-58.4% -25.4%
From 52-week high -20.4%-20.6%-53.8% -2.5%
52-week high $170.49$130.59$99.94 $779.14
52-week low $123.73$82.56$41.62 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultiplePEPABTMNST
P/E now vs peer median 17.0xmedian 27.0x 33.3xmedian 30.7x 42.5xmedian 27.0x
P/S now vs peer median 1.9xmedian 1.6x 3.9xmedian 3.0x 9.8xmedian 1.6x
EV/EBITDA now vs peer median 12.1xmedian 14.4x 19.1xmedian 17.7x 31.0xmedian 14.4x
P/FCF now vs peer median 17.7xmedian 18.3x 22.9xmedian 23.7x 43.1xmedian 18.3x
P/B now vs peer median 8.2xmedian 2.8x 3.5xmedian 2.4x 9.7xmedian 2.8x
PEG now vs peer median 1.71median 2.03 18.30median 0.96 2.54median 2.03

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsPEPABTMNST
Revenue $98.24B $46.59B $9.22B
Gross profit $53.22B $26.37B $5.12B
Operating income $15.05B $7.35B $2.69B
Net income $10.97B $5.43B $2.13B
Free cash flow $10.47B $7.82B $2.10B
R&D – $3.16B –
EPS (diluted) $7.97 $3.11 $1.08
Cash & equivalents $10.68B $5.10B $2.19B
Total debt $208.67B $32.61B –
Shares (diluted) 1.37B 1.74B 1.98B
Enterprise value $142.41B $152.69B $79.16B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricPEPABTMNST
P/E 17.0x 33.3x 42.5x
P/FCF 17.7x 22.9x 43.1x
P/Operating cash flow 12.7x 18.1x 40.4x
P/S 1.9x 3.9x 9.8x
P/B 8.2x 3.5x 9.7x
P/Tangible book 21.7x 5.2x 11.3x
EV/EBITDA 12.1x 19.1x 31.0x
EV/EBIT 15.0x 28.1x 32.4x
EV/Revenue 2.3x 4.4x 9.4x
EV/FCF 21.6x 26.4x 41.5x
EV/Operating cash flow 15.5x 20.8x 38.9x
PEG (3Y EPS CAGR) 1.71 18.30 2.54

Growth

14 metrics
MetricPEPABTMNST
Revenue growth (1Y) 6.4% 8.1% 20.4%
Revenue CAGR (3Y) 2.4% 5.0% 11.3%
Gross profit growth (1Y) 6.8% 9.2% 21.2%
Gross profit CAGR (3Y) 2.5% 5.9% 13.6%
Operating income growth (1Y) 47.7% -2.2% 30.3%
Operating income CAGR (3Y) 10.6% 6.2% 13.9%
Net income growth (1Y) 50.8% -61.2% 35.2%
Net income CAGR (3Y) 9.4% 1.7% 14.0%
EPS growth (1Y) 51.4% -61.0% 34.6%
EPS CAGR (3Y) 10.0% 1.8% 16.7%
Operating cash flow growth (1Y) 23.9% 9.6% 9.0%
Operating cash flow CAGR (3Y) 6.3% 9.9% 13.8%
Free cash flow growth (1Y) 54.3% 15.5% 13.1%
Free cash flow CAGR (3Y) 14.7% 12.5% 15.9%

Profitability

14 metrics
MetricPEPABTMNST
Gross margin 54.2% 56.6% 55.5%
EBITDA margin 19.1% 23.2% 30.5%
Operating margin 15.3% 15.8% 29.2%
Pretax margin 14.0% 16.1% 30.1%
Net margin 11.1% 11.6% 23.1%
FCF margin 10.7% 16.8% 22.8%
Operating cash flow margin 14.8% 21.3% 24.3%
Return on equity 49.0% 10.4% 23.5%
Return on assets 9.8% 4.9% 19.1%
Return on invested capital 16.1% 6.2% –
Return on capital employed 19.4% 8.0% 28.6%
Asset turnover 0.9x 0.4x 0.8x
Cash conversion (OCF / net income) 1.3x 1.8x 1.1x
Stock comp / revenue 0.3% 1.5% 1.5%

Financial Health

11 metrics
MetricPEPABTMNST
Debt / assets 46.3% 29.9% –
Debt / equity 2.3x 0.6x –
Net debt / EBITDA 2.2x 2.5x –
Debt / FCF 5.0x 4.2x –
Liabilities / assets 79.9% 52.6% 17.7%
Equity / assets 20.1% 47.4% 82.3%
Interest coverage 13.6x 9.6x –
Current ratio 0.9x 1.4x 3.7x
Quick ratio 0.7x 0.8x 3.1x
Cash ratio 0.3x 0.3x 2.0x
Altman Z-score 3.48 3.23 30.28

Shareholder Returns

7 metrics
MetricPEPABTMNST
Dividend yield 4.3% 2.4% –
Net buyback yield 0.5% 0.9% 0.1%
Shareholder yield 4.7% 3.3% 0.1%
Payout ratio (earnings) – 78.5% –
Payout ratio (FCF) – 54.5% –
Dividend growth (1Y) – 7.2% –
Dividend CAGR (3Y) – 7.5% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusPEPABTMNST
Forward P/E 15.8xFY2026 18.2xFY2026 38.5xFY2026
EPS, next fiscal year $8.60FY2026 $5.69FY2026 $1.20FY2026
EPS growth, next FY +5.7%FY2026 +10.5%FY2026 +16.5%FY2026
EPS growth, the year after +3.1% +12.8% +5.8%
Revenue, next fiscal year $96.42BFY2026 $53.32BFY2026 $10.20BFY2026
Revenue growth, next FY +2.7%FY2026 +20.3%FY2026 +23.0%FY2026
Revenue growth, the year after +11.4% -1.0% +2.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersPEPABTMNST
Held by institutions 79.1% 79.2% 67.5%
Institutions holding 3,414 2,977 1,359
Change in shares held, QoQ +5.8% +0.3% +2.9%
Institutions buying 1,500 1,258 738
Institutions selling 1,515 1,376 456
Buyers to sellers 0.99 0.91 1.62

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

PEPABTMNST
PEP 1.00 0.32 0.15
ABT 0.32 1.00 0.03
MNST 0.15 0.03 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, PEP, ABT and MNST?

Pepsico (PEP) is the largest by market capitalisation: Pepsico (PEP) $184.65B, Abbott Laboratories (ABT) $182.26B, Monster Beverage (MNST) $90.91B.

Which stock is cheaper, PEP, ABT and MNST?

Pepsico (PEP) trades on the lowest price-to-earnings ratio (Pepsico (PEP) 16.9x, Abbott Laboratories (ABT) 33.6x, Monster Beverage (MNST) 42.7x). On next year's consensus earnings, Pepsico (PEP) is cheapest (Pepsico (PEP) 15.8x, Abbott Laboratories (ABT) 18.2x, Monster Beverage (MNST) 38.5x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Monster Beverage (MNST) grew revenue fastest over the trailing twelve months: Pepsico (PEP) +6.4%, Abbott Laboratories (ABT) +8.1%, Monster Beverage (MNST) +20.4%.

Which company is more profitable?

Monster Beverage (MNST) has the highest net margin (Pepsico (PEP) 11.1%, Abbott Laboratories (ABT) 11.6%, Monster Beverage (MNST) 23.1%). On return on invested capital, Pepsico (PEP) leads (Pepsico (PEP) 16.1%, Abbott Laboratories (ABT) 6.2%).

Which stock has performed better?

Over the past year Pepsico (PEP) returned the most: Pepsico (PEP) -10.4%, Abbott Laboratories (ABT) -17.9%, Monster Beverage (MNST) -33.9%. Over five years, Monster Beverage (MNST) compounded fastest (Pepsico (PEP) -3.2%/yr, Abbott Laboratories (ABT) -3.9%/yr, Monster Beverage (MNST) +1.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Pepsico (PEP) 0.00%, Abbott Laboratories (ABT) 0.02%, Monster Beverage (MNST) 0.00%. Pepsico (PEP) and Monster Beverage (MNST) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Pepsico (PEP) has been the steadiest (Pepsico (PEP) 21.4%, Abbott Laboratories (ABT) 27.4%, Monster Beverage (MNST) 73.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, PEP, ABT and MNST?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Pepsico (PEP) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.